Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
Liyuan Peng, Jingwen Jiang, Bo Tang, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10360-10377
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications
Hui Ming, Bowen Li, Li Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188519-188519
Closed Access | Times Cited: 73
Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer
Kübra Kaban, Clemens Hinterleitner, Yanjun Zhou, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 61
Nanomaterials‐Based Targeting of Long Non‐Coding RNAs in Cancer: A Cutting‐Edge Review of Current Trends
Fatemeh Davodabadi, Bahareh Farasati Far, Saman Sargazi, et al.
ChemMedChem (2024) Vol. 19, Iss. 8
Closed Access | Times Cited: 11
GAS5 lncRNA: A biomarker and therapeutic target in breast cancer
Lakshmi Thangavelu, Ehssan Moglad, Gaurav Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155424-155424
Closed Access | Times Cited: 10
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer
Negin Karamali, Arshia Daraei, Arman Rostamlou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci
Marina Aznaourova, Nils Schmerer, Bernd Schmeck, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 59
The biogenesis and biological function of PIWI-interacting RNA in cancer
Silu Chen, Shuai Ben, Junyi Xin, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 55
Artificial Intelligence Breakthroughs in Pioneering Early Diagnosis and Precision Treatment of Breast Cancer: A Multimethod Study
Mohammad Reza Darbandi, Mahsa Darbandi, Sara Darbandi, et al.
European Journal of Cancer (2024) Vol. 209, pp. 114227-114227
Closed Access | Times Cited: 8
Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway
Ji Jiang, Yan Yang, Fuhuan Wang, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 6
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics
Subhasmita Bhal, Chanakya Nath Kundu
Medical Oncology (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 14
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
Seyedeh Tayebeh Ahmadpour, Charlotte Orré, Priscila Bertevello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15897-15897
Open Access | Times Cited: 14
The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway
Maonan Wang, Manli Dai, Dan Wang, et al.
Cancer Letters (2021) Vol. 512, pp. 60-72
Open Access | Times Cited: 31
Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Extracellular vesicle‐LncRNA HOTAIR modulates esophageal cancer chemoresistance and immune microenvironment via miR‐375/CDH2 pathway
Tayier Tuersong, Munire Shataer, Yan Chen, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 2
Open Access
LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases
Shifeng Huang, Xiaofei Peng, Lianggui Jiang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
Cuicui Lu, Duncan Wei, Yahui Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer
Juan Wang, Fan Yang, Jialang Zhuang, et al.
The International Journal of Biochemistry & Cell Biology (2021) Vol. 143, pp. 106140-106140
Closed Access | Times Cited: 20
The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers
Faiza Naz, Imran Tariq, Sajid Ali, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6102-6102
Open Access | Times Cited: 18
Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer
Jiehui Cai, Zeqi Ji, Jinyao Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
Liqin Yao, Junfeng Chen, Wenxue Ma
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
LncRNA-42060 Regulates Tamoxifen Sensitivity and Tumor Development via Regulating the miR-204-5p/SOX4 Axis in Canine Mammary Gland Tumor Cells
Enshuang Xu, Mengxin Hu, Reidong Ge, et al.
Frontiers in Veterinary Science (2021) Vol. 8
Open Access | Times Cited: 17
Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling pathway
Yunwei Zhang, Yunping Guan, Xinyu Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Neutrophil extracellular traps-related lncRNAs prognostic signature for gastric cancer and immune infiltration: potential biomarkers for predicting overall survival and clinical therapy
Shuhan Yang, Jiahui Liang, Xin Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top